Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Medical Genetics. Part A|April 4, 2017
Neurofibromatosis type 2: Multiple intra-dermal tumors in a toddlerCecilie F Rustad, Hilde M Dahl, Naomi L Bowers, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
American Journal of Human Genetics|June 11, 2004
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based studyMichael E Baser, Lisa Kuramoto, Harry Joe, et al.
Journal of Medical Genetics|July 2, 2013
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosisEmma Mm Burkitt Wright, Emma Sach, Saba Sharif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition SyndromeWilliam D Foulkes, Junne Kamihara, D Gareth R Evans, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
Neurogenetics|March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1D Gareth R Evans, Hector Salvador, Vivian Y Chang, et al.
European Journal of Human Genetics : EJHG|June 23, 2011
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989D Gareth R Evans, Catherine O'Hara, Anna Wilding, et al.
JAMA Network Open|April 19, 2024
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic VariantsZhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Medical Genetics. Part A|April 4, 2017
Neurofibromatosis type 2: Multiple intra-dermal tumors in a toddlerCecilie F Rustad, Hilde M Dahl, Naomi L Bowers, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
American Journal of Human Genetics|June 11, 2004
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based studyMichael E Baser, Lisa Kuramoto, Harry Joe, et al.
Journal of Medical Genetics|July 2, 2013
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosisEmma Mm Burkitt Wright, Emma Sach, Saba Sharif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition SyndromeWilliam D Foulkes, Junne Kamihara, D Gareth R Evans, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
Neurogenetics|March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1D Gareth R Evans, Hector Salvador, Vivian Y Chang, et al.
European Journal of Human Genetics : EJHG|June 23, 2011
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989D Gareth R Evans, Catherine O'Hara, Anna Wilding, et al.
JAMA Network Open|April 19, 2024
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic VariantsZhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, et al.
Pageof 11